Global Women's Health Academy

The Importance of Non-invasive Prenatal Testing in All Pregnant Women

Dr. Lee Shulman discusses the background of NIPT, including the advantages, risks, limitations and differences in various screening tests.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    With fetal chromosomal abnormalities being a common cause of congenital malformation and miscarriages, screening for these abnormalities has for many years been identified by ACOG as an important component of obstetrical care. Noninvasive prenatal testing provides means to screen women for these chromosomal abnormalities that offer high levels of sensitivity and specificity.

    Join us as Dr. Lee Shulman discusses the background of NIPT, including the advantages, risks, limitations and differences in the various screening tests that are available.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Lee Philip Shulman, MD, FACOG, FACMG
    Anna Ross Lapham Professor in Obstetrics and Gynecology
    Chief, Division of Reproductive Genetics
    Medical Director, Graduate Program in Genetic Counseling
    Feinberg School of Medicine
    Northwestern University
    Chicago, IL

    Dr. Shulman receives consulting fees from Allergan, CombiMatrix, Sequenom Inc., and Sera and is a speaker for Allergan, Merck, Sequenom Inc., and Sera.


    • Sean T. Barrett, CHCP has nothing to disclose.
    • Martin R. Chavez, MD, FACOG receives consulting fees from and is a speaker for Illumina Inc. and Progenity Inc.
    • Kia K. Gray, MPH has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Robert Schneider has nothing to disclose.
    • Jennifer Spear Smith, PhD has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Overcome barriers and demonstrate competency in integrating the 2016 ACOG/SMFM Non-invasive Prenatal Testing for Fetal Aneuploidy Committee Opinion
    • Explain the benefits and disadvantages of traditional fetal chromosomal aneuploidy screening tests compared with the evolving, non-invasive screening test
    • Incorporate appropriate screening and diagnostic protocols according to evidence-based guidelines and latest technologies into clinical decision-making for assessing fetal chromosomal aneuploidies
    • Explain the evolving role of NIPT in a general obstetrical population 
  • Target Audience

    This activity is designed to meet the educational needs of Maternal Fetal Medicine specialists, Obstetrician/Gynecologists, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives and Genetic Counselors.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Commercial Support

    This activity is supported by an independent educational grant from Roche Diagnostics.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience."

Facebook Comments

Sign-up for the Global Women's Health Academy newsletters.
Comprehensive Women's Health Education.

Better education for a better you.

* Required